Pulmonary Disease · San Juan, PR
NPI
1184614927
Since 2005
Specialty
Pulmonary Disease
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
400 Ave Fd Roosevelt, Edif Clinica Las Americas Ofic 205
San Juan, PR, 00918
Phone (787) 765-1919
Groups this clinician bills Medicare through
Medicare paid, 2024
$118K
1,222 services
Medicare patients, 2024
371
Average age 75
Drug cost, 2024
$850K
6,046 prescriptions
Company payments, 2025
$1,809
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maximo C Blondet Passalacqua was code 99213 (office e&m - established), 330 times for 137 patients. In total Maximo C Blondet Passalacqua billed 1,222 services in 21 codes, and Medicare paid $118K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-06-07.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 330 | 137 | $61.99 | $20K |
| 94660 Treatment - Miscellaneous | Office | 262 | 149 | $47.81 | $13K |
| 94375 Pulmonary Function Testing | Office | 110 | 92 | $26.66 | $2,933 |
| 95811 Sleep Study | Office | 92 | 92 | $492.84 | $45K |
| 94727 Pulmonary Function Testing | Office | 79 | 78 | $31.41 | $2,482 |
| 94729 Pulmonary Function Testing | Office | 78 | 77 | $39.21 | $3,058 |
| 99233 Hospital E&M - Subsequent | Facility | 78 | 33 | $91.73 | $7,155 |
| 95810 Sleep Study | Office | 28 | 28 | $463.75 | $13K |
| 90658 Vaccine Product | Office | 24 | 24 | $21.41 | $514 |
| G0008 Administration of influenza virus vaccine | Office | 24 | 24 | $15.58 | $374 |
| G0009 Administration of pneumococcal vaccine | Office | 12 | 12 | $15.58 | $187 |
| 90677 Vaccine Product | Office | 12 | 12 | $278.05 | $3,337 |
By year: 2022 $114K for 1,177 services; 2023 $119K for 1,172 services; 2024 $118K for 1,222 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maximo C Blondet Passalacqua prescribed most often to Medicare patients was Montelukast Sodium, with 1,416 prescriptions and refills. In total Maximo C Blondet Passalacqua wrote 6,046 Medicare prescriptions that cost $850K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,416 | 2,089 | 383 | $17K |
| Fluticasone Propionate Generic | 770 | 872 | 230 | $16K |
| Dexamethasone Generic | 608 | 608 | 238 | $11K |
| Azithromycin Generic | 603 | 603 | 313 | $5,164 |
| Methylprednisolone Generic | 317 | 317 | 175 | $3,420 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 229 | 235 | 54 | $149K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 217 | 250 | 71 | $9,839 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 178 | 190 | 55 | $38K |
| Levocetirizine Dihydrochloride Generic | 172 | 203 | 47 | $2,180 |
| Symbicort Budesonide/Formoterol Fumarate | 145 | 147 | 54 | $35K |
| Clonazepam Generic | 143 | 143 | 25 | $966 |
| Azelastine Hcl Generic | 90 | 227 | 45 | $2,278 |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 88 | 98 | 40 | $5,201 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 87 | 108 | 34 | $8,394 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 86 | 86 | 15 | $42K |
Brand drugs: 1,191 claims; generic drugs: 4,855 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maximo C Blondet Passalacqua $1,809 ($1,809 in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $507.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 19 | $507 |
| Jazz Pharmaceuticals Inc. JAZZ | 6 | $259 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $199 |
| Viatris Specialty LLC | 6 | $158 |
| Merck Sharp & Dohme LLC MRK | 6 | $138 |
| Pbg Puerto Rico LLC | 4 | $92.36 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $88.99 |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 3 | $73.87 |
| GlaxoSmithKline, LLC. GSK | 3 | $73.16 |
| Genzyme Corporation SNY | 2 | $50 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.